SecBot SecBot
3 ·Filed Jul 30, 2026

CBLL

Ceribell, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001193125-26-326489
Actionable Insight • Neutral

Monitor for future Form 4 filings by Thomas A. West to gauge insider trading activity. This Form 3 is purely administrative and has no immediate trading implications.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
CBLL ▲ +52.80% at T+60d
NEUTRAL call +52.80% · α vs SPY +50.34% · entry $17.69 → $27.03
Entry = T+0 close
Jul 30, 2026
via day close
T+1d
+3.50%
call +3.50% · α +2.08%
$18.31
settled 3mo ago
T+5d
+6.33%
call +6.33% · α +2.82%
$18.81
settled 3mo ago
T+20d
+34.14%
call +34.14% · α +31.16%
$23.73
settled 2mo ago
T+60d
+52.80%
call +52.80% · α +50.34%
$27.03
settled 4d ago

Price Chart

Loading chart...

Executive Summary

Thomas A. West filed an initial statement of beneficial ownership (Form 3) with Ceribell, Inc., along with a power of attorney authorizing company officers to handle future Section 16 filings. This is a routine administrative filing required upon becoming a reporting person and contains no financial data or trading activity.

Key Facts

  • Thomas A. West filed a Form 3 initial statement of beneficial ownership with Ceribell, Inc.
  • A power of attorney (Ex-24.1) was also filed, appointing the CEO, CFO, General Counsel, and Principal Accounting Officer as attorneys-in-fact for Section 16 filings.
  • The filing is dated July 28, 2026, and was accepted by the SEC on July 30, 2026.
  • No securities ownership amounts or transaction details are disclosed in the filing.

Financial Impact

No financial impact — administrative filing only.

Risk Factors

  • No material risks identified from this administrative filing.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (CBLL) — Batch item 10001193125-26-326489
Document: 0001193125-26-326489-index-headers.html0001193125-26-326489
Document: 0001193125-26-326489-index.html0001193125-26-326489
Document: 0001193125-26-326489.txt0001193125-26-326489
3 Filing (CBLL) — Batch item 50001193125-26-326489
Document: 0001193125-26-326489-index-headers.html0001193125-26-326489
Document: 0001193125-26-326489-index.html0001193125-26-326489
Document: 0001193125-26-326489.txt0001193125-26-326489
29 reports for CBLL
Performance horizon
73% Hit rate @ T+1 8 of 11 directional calls Went positive at some point 9 of 11 best @ T+60▲ +17.06%Feb 23, 2026
Filters
Rows
Reports for CBLL — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
Press Release
NEUTRAL ★ 1/10
$27.14 $27.40▲ +0.96%▲ +2.14%$27.00 (−0.50%)
Sep 17, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.37 $24.25▼ −0.49%▼ −2.04%$27.00 (+10.81%)
Sep 10, 2026
6w ago
Insider Cluster
BEARISH ★ 5/10
$23.63 $24.33▼ −2.96%▼ −3.41%$27.00 (−14.28%)
Sep 4, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.31 $24.41▲ +0.41%▲ +0.88%$27.00 (+11.09%)
Aug 25, 2026
8w ago
Insider Cluster
BEARISH ★ 5/10
$23.45 $23.37▲ +0.34%▲ +1.00%$27.00 (−15.16%)
Aug 20, 2026
9w ago
Insider Cluster
BEARISH ★ 5/10
$24.20 $23.94▲ +1.07%▲ +0.78%$27.00 (−11.59%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.20 $23.94▼ −1.07%▼ −0.78%$27.00 (+11.59%)
Aug 18, 2026
10w ago
Institutional Cluster
BULLISH ★ 5/10
$24.21 $24.89▲ +2.81%▲ +2.60%$27.00 (+11.54%)
Aug 10, 2026
11w ago
8-K
BULLISH ★ 7/10
$21.31 $22.91▲ +7.51%▲ +7.26%$27.00 (+26.72%)
Aug 10, 2026
11w ago
Press Release
MIXED ★ 6/10
$21.31 $22.91▲ +7.51%▲ +7.26%$27.00 (+26.72%)
Showing 10 of 29

US Market Status

Market Open — Closes in 5h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 30, 2026